ATE402706T1 - Im mund zerfallende pharmazeutische zusammensetzung mit risperidon - Google Patents
Im mund zerfallende pharmazeutische zusammensetzung mit risperidonInfo
- Publication number
- ATE402706T1 ATE402706T1 AT05757277T AT05757277T ATE402706T1 AT E402706 T1 ATE402706 T1 AT E402706T1 AT 05757277 T AT05757277 T AT 05757277T AT 05757277 T AT05757277 T AT 05757277T AT E402706 T1 ATE402706 T1 AT E402706T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing risperidone
- risperidone
- polymethacrylate
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001534 risperidone Drugs 0.000 title abstract 2
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920000193 polymethacrylate Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004028940A DE102004028940A1 (de) | 2004-06-15 | 2004-06-15 | Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE402706T1 true ATE402706T1 (de) | 2008-08-15 |
Family
ID=34971693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05757277T ATE402706T1 (de) | 2004-06-15 | 2005-06-14 | Im mund zerfallende pharmazeutische zusammensetzung mit risperidon |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1768673B1 (de) |
| AT (1) | ATE402706T1 (de) |
| DE (2) | DE102004028940A1 (de) |
| EA (1) | EA010178B1 (de) |
| ES (1) | ES2311230T3 (de) |
| HR (1) | HRP20080452T3 (de) |
| NO (1) | NO20070187L (de) |
| PL (1) | PL1768673T3 (de) |
| PT (1) | PT1768673E (de) |
| RS (1) | RS50609B (de) |
| SI (1) | SI1768673T1 (de) |
| UA (1) | UA87692C2 (de) |
| WO (1) | WO2005123084A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080085310A1 (en) * | 2006-10-06 | 2008-04-10 | Maria Oksana Bachynsky | Capecitabine rapidly disintegrating tablets |
| JP5275815B2 (ja) * | 2006-12-26 | 2013-08-28 | 塩野義製薬株式会社 | リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤 |
| CN101269014B (zh) * | 2007-03-21 | 2012-11-14 | 江苏万特制药有限公司 | 一种利培酮的口腔崩解片及其制备方法 |
| WO2008152729A1 (ja) * | 2007-06-15 | 2008-12-18 | Teikokumedix Co., Ltd. | リスペリドンを含むゼリー状の医薬組成物 |
| CN101485636B (zh) * | 2008-01-14 | 2010-12-22 | 齐鲁制药有限公司 | 利培酮口腔崩解片及其制备方法 |
| WO2013095314A1 (en) * | 2011-12-19 | 2013-06-27 | Mahmut Bilgic | Pharmaceutical formulations comprising risperidone |
| WO2013100876A1 (en) * | 2011-12-27 | 2013-07-04 | Mahmut Bilgic | Risperidone formulations |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69710460T2 (de) * | 1996-06-17 | 2002-10-02 | Janssen Pharmaceutica N.V., Beerse | Bikonvexe, rasch desintegrierende verabreichungsformen |
| US7919119B2 (en) * | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| JP4019374B2 (ja) * | 2001-07-27 | 2007-12-12 | アステラス製薬株式会社 | 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法 |
| US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
| JP4739217B2 (ja) * | 2003-05-07 | 2011-08-03 | サムヤン コーポレイション | 速く溶ける錠剤を製造するための高可塑性顆粒 |
| WO2005120463A1 (en) * | 2004-06-09 | 2005-12-22 | Ranbaxy Laboratories Limited | Rapidly disintegrating tablets of risperidone |
-
2004
- 2004-06-15 DE DE102004028940A patent/DE102004028940A1/de not_active Withdrawn
-
2005
- 2005-06-14 AT AT05757277T patent/ATE402706T1/de not_active IP Right Cessation
- 2005-06-14 PT PT05757277T patent/PT1768673E/pt unknown
- 2005-06-14 EP EP05757277A patent/EP1768673B1/de not_active Expired - Lifetime
- 2005-06-14 PL PL05757277T patent/PL1768673T3/pl unknown
- 2005-06-14 RS RSP-2008/0419A patent/RS50609B/sr unknown
- 2005-06-14 ES ES05757277T patent/ES2311230T3/es not_active Expired - Lifetime
- 2005-06-14 WO PCT/EP2005/006375 patent/WO2005123084A1/en not_active Ceased
- 2005-06-14 DE DE602005008607T patent/DE602005008607D1/de not_active Expired - Lifetime
- 2005-06-14 SI SI200530422T patent/SI1768673T1/sl unknown
- 2005-06-14 EA EA200700023A patent/EA010178B1/ru not_active IP Right Cessation
- 2005-06-14 UA UAA200700399A patent/UA87692C2/ru unknown
- 2005-06-14 HR HR20080452T patent/HRP20080452T3/xx unknown
-
2007
- 2007-01-11 NO NO20070187A patent/NO20070187L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2311230T3 (es) | 2009-02-01 |
| EA010178B1 (ru) | 2008-06-30 |
| PL1768673T3 (pl) | 2009-01-30 |
| UA87692C2 (ru) | 2009-08-10 |
| DE602005008607D1 (de) | 2008-09-11 |
| EP1768673A1 (de) | 2007-04-04 |
| WO2005123084A1 (en) | 2005-12-29 |
| NO20070187L (no) | 2007-03-02 |
| PT1768673E (pt) | 2008-10-21 |
| SI1768673T1 (sl) | 2008-12-31 |
| EA200700023A1 (ru) | 2007-06-29 |
| HRP20080452T3 (hr) | 2008-10-31 |
| EP1768673B1 (de) | 2008-07-30 |
| DE102004028940A1 (de) | 2006-01-12 |
| RS50609B (sr) | 2010-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200744602A (en) | Administration of dipeptidyl peptidase inhibitors | |
| MEP18208A (en) | Immune response modifier foam formulations | |
| MX2009002772A (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo. | |
| CY1108700T1 (el) | Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης | |
| TN2009000362A1 (en) | Weekly administration of dipeptidyl peptidase inhibitors | |
| CY1117021T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιεχουν νιλοτινιβη ή αλας αυτης | |
| SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| HRP20090194T1 (hr) | Suha granulirana kompozicija koja sadrži emtricitabin i tenofovir df | |
| EP1458362A4 (de) | Pharmazeutische zusammensetzungen in teilchenform | |
| EP1971308A4 (de) | Trägerzusammensetzung zur topischen verabreichung und diese enthaltende therapeutische formulierungen | |
| NO20075111L (no) | Farmasoytisk sammensetning | |
| DE60312049D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
| GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| NO20070187L (no) | Oralt desintegrerende farmasoytisk preparat omfattende risperidon | |
| MX2007001953A (es) | Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer. | |
| EA200701172A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение | |
| ATE357220T1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
| TW200640858A (en) | Substituted pyrroles, compositions containing them, method of manufacture and use | |
| EP1850829A4 (de) | Neue propofolzusammensetzung mit ascorbinsäure oder pharmazeutisch nutzbaren salzen davon | |
| ATE439841T1 (de) | Pharmazeutische zusammensetzungen mit zd6474 | |
| DE602005005033D1 (de) | Sprühgetrocknete pharmazeutische zusammensetzungen | |
| TW200608982A (en) | Oral formulations of paricalcitol | |
| DE50211461D1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum | |
| ATE460421T1 (de) | Phosphinsäurederivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |